Macrogenics (MGNX) Gross Profit (2020 - 2025)

Macrogenics (MGNX) has 6 years of Gross Profit data on file, last reported at $41.2 million in Q4 2025.

• Gross Profit for Q4 2025 came in at $41.2 million, up 3.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $149.5 million (down 7.87% YoY), and the FY2025 annual result was $149.5 million, changed 0.26% from the prior year.
• Gross Profit slipped to $41.2 million in Q4 2025 per MGNX's latest filing, from $72.8 million in the prior quarter.
• Over five years, Gross Profit peaked at $110.5 million in Q3 2024 and troughed at $3.1 million in Q2 2024.
• A 5-year average of $29.7 million and a median of $19.6 million in 2021 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2023 and 2024: Gross Profit sank 85.53% in 2023, then soared 971.96% in 2024.
• A 5-year view of Gross Profit shows it stood at $13.2 million in 2021, then surged by 452.9% to $73.0 million in 2022, then slumped by 85.53% to $10.6 million in 2023, then soared by 276.69% to $39.8 million in 2024, then climbed by 3.67% to $41.2 million in 2025.
• Business Quant data shows MGNX's Gross Profit at $41.2 million in Q4 2025, $72.8 million in Q3 2025, and $22.2 million in Q2 2025.